Ads
related to: AMGNget.dtitrader.com has been visited by 10K+ users in the past month
Search results
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 6 days agoAmgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
AMGEN Inc. (AMGN) Shares Plummet Below 1-Year High – News Heater
NewsHeater· 4 days agoThe stock of AMGEN Inc. (NASDAQ: AMGN) has decreased by -1.27 when compared to last closing price of 300.19. Despite this, the company has experienced a -5.87% fall in its ...
Should you buy Amgen’s stock above $300? | Invezz
Invezz· 2 days agoAmgen Inc. (NASDAQ:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. The U.S. FDA has approved Amgen’s...
Where Will Amgen Be in 3 Years?
Motley Fool via Yahoo Finance· 4 days agoIf you're looking for an investment in the pharmaceutical sector and you don't already own shares of Amgen (NASDAQ: AMGN), it might be worth considering...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 4 days agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 3 days agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock
Fed official's blunt warning resets rate cut chances
TheStreet via Yahoo Finance· 4 days agoThe biggest Dow winners were Home Depot (HD) and Intel (INTC) , up 1.1% each. The laggards were health-related: Amgen (AMGN) and Merck (MRK) , down about...
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
WKBN 27 Youngstown· 5 days agoAmgen (NASDAQ:AMGN) today announced the presentation of new data from its broad oncology portfolio at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, ...
Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
Zacks via Yahoo Finance· 6 days agoSince 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters· 5 days agoThe U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to...